首页> 外文OA文献 >Novel candidate genes and a wide spetrum of structural and point mutations responsible for inherited retinal dystrophies revealed by exome sequencing
【2h】

Novel candidate genes and a wide spetrum of structural and point mutations responsible for inherited retinal dystrophies revealed by exome sequencing

机译:外显子组测序揭示了新型候选基因以及广泛的结构和点突变,这些遗传和结构突变导致遗传性视网膜营养不良

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: NGS-based genetic diagnosis has completely revolutionized the human genetics field. In this study, we have aimed to identify new genes and mutations by Whole Exome Sequencing (WES) responsible for inherited retinal dystrophies (IRD). Methods: A cohort of 33 pedigrees affected with a variety of retinal disorders was analysed by WES. Initial prioritization analysis included around 300 IRD-associated genes. In non-diagnosed families a search for pathogenic mutations in novel genes was undertaken. Results: Genetic diagnosis was attained in 18 families. Moreover, a plausible candidate is proposed for 10 more cases. Two thirds of the mutations were novel, including 4 chromosomal rearrangements, which expand the IRD allelic heterogeneity and highlight the contribution of private mutations. Our results prompted clinical re-evaluation of some patients resulting in assignment to a syndromic instead of non-syndromic IRD. Notably, WES unveiled four new candidates for non-syndromic IRD: SEMA6B, CEP78, CEP250, SCLT1, the two latter previously associated to syndromic disorders. We provide functional data supporting that missense mutations in CEP250 alter cilia formation. Conclusion: The diagnostic efficiency of WES, and strictly following the ACMG/AMP criteria is 55% in reported causative genes or functionally supported new candidates, plus 30% families in which likely pathogenic or VGUS/VUS variants were identified in plausible candidates. Our results highlight the clinical utility of WES for molecular diagnosis of IRD, provide a wider spectrum of mutations and concomitant genetic variants, and challenge our view on syndromic vs non-syndromic, and causative vs modifier genes.
机译:背景:基于NGS的遗传诊断彻底改变了人类遗传学领域。在这项研究中,我们旨在通过负责遗传性视网膜营养不良症(IRD)的全外显子组测序(WES)识别新基因和突变。方法:通过WES分析了33名家系,他们受各种视网膜疾病的影响。最初的优先级分析包括约300个与IRD相关的基因。在未经诊断的家庭中,进行了寻找新基因中的致病性突变的研究。结果:18个家庭获得了遗传诊断。此外,对于另外10个案件,提出了一个合理的候选人。突变的三分之二是新颖的,包括4个染色体重排,扩展了IRD等位基因的异质性并突出了私人突变的作用。我们的结果促使对某些患者进行临床重新评估,导致他们被分配到综合症而不是非综合症IRD。值得注意的是,WES公布了非综合症IRD的四种新候选药物:SEMA6B,CEP78,CEP250,SCLT1,后者先前与综合症有关。我们提供的功能数据支持CEP250中的错义突变会改变纤毛的形成。结论:严格按照ACMG / AMP标准,WES的诊断效率在报告的致病基因或功能支持的新候选基因中占55%,另外还有30%的家族在合理的候选物中鉴定出可能的病原体或VGUS / VUS变体。我们的结果突出了WES在IRD分子诊断中的临床应用,提供了更广泛的突变和伴随的遗传变异,并挑战了我们对有症状性与非症状性,致病性与修饰性基因的看法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号